Logo image of MRD.CA

MELCOR DEVELOPMENTS LTD (MRD.CA) Stock Fundamental Analysis

Canada - TSX:MRD - CA5854671032 - Common Stock

14.5 CAD
-0.25 (-1.69%)
Last: 11/3/2025, 7:00:00 PM
Fundamental Rating

5

MRD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Real Estate Management & Development industry. MRD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MRD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MRD had positive earnings in the past year.
MRD had a positive operating cash flow in the past year.
MRD had positive earnings in each of the past 5 years.
Each year in the past 5 years MRD had a positive operating cash flow.
MRD.CA Yearly Net Income VS EBIT VS OCF VS FCFMRD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

MRD has a Return On Assets (0.48%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 0.78%, MRD is in line with its industry, outperforming 46.67% of the companies in the same industry.
MRD has a better Return On Invested Capital (5.20%) than 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MRD is significantly below the industry average of 11.13%.
The 3 year average ROIC (3.82%) for MRD is below the current ROIC(5.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.48%
ROE 0.78%
ROIC 5.2%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
MRD.CA Yearly ROA, ROE, ROICMRD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

The Profit Margin of MRD (2.54%) is comparable to the rest of the industry.
MRD's Profit Margin has declined in the last couple of years.
MRD has a Operating Margin of 37.62%. This is in the better half of the industry: MRD outperforms 70.00% of its industry peers.
MRD's Operating Margin has improved in the last couple of years.
The Gross Margin of MRD (47.53%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MRD has remained more or less at the same level.
Industry RankSector Rank
OM 37.62%
PM (TTM) 2.54%
GM 47.53%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
MRD.CA Yearly Profit, Operating, Gross MarginsMRD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

MRD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MRD has less shares outstanding
The number of shares outstanding for MRD has been reduced compared to 5 years ago.
Compared to 1 year ago, MRD has an improved debt to assets ratio.
MRD.CA Yearly Shares OutstandingMRD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MRD.CA Yearly Total Debt VS Total AssetsMRD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.62, we must say that MRD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.62, MRD is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
MRD has a debt to FCF ratio of 4.52. This is a neutral value as MRD would need 4.52 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.52, MRD belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
A Debt/Equity ratio of 0.49 indicates that MRD is not too dependend on debt financing.
The Debt to Equity ratio of MRD (0.49) is better than 76.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.52
Altman-Z 1.62
ROIC/WACC0.74
WACC6.99%
MRD.CA Yearly LT Debt VS Equity VS FCFMRD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MRD has a Current Ratio of 4.32. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.32, MRD belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
MRD has a Quick Ratio of 4.32. This indicates that MRD is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MRD (4.32) is better than 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 4.32
MRD.CA Yearly Current Assets VS Current LiabilitesMRD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

MRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.78%.
Measured over the past years, MRD shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.67% on average per year.
MRD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.26%.
The Revenue has been growing by 10.94% on average over the past years. This is quite good.
EPS 1Y (TTM)-88.78%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-68.66%
Revenue 1Y (TTM)14.26%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%43.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRD.CA Yearly Revenue VS EstimatesMRD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MRD.CA Yearly EPS VS EstimatesMRD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

MRD is valuated quite expensively with a Price/Earnings ratio of 51.79.
MRD's Price/Earnings ratio is in line with the industry average.
MRD is valuated expensively when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.21, the valuation of MRD can be described as very cheap.
Based on the Price/Forward Earnings ratio, MRD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
MRD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.27.
Industry RankSector Rank
PE 51.79
Fwd PE 7.21
MRD.CA Price Earnings VS Forward Price EarningsMRD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MRD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MRD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.29
EV/EBITDA 6.6
MRD.CA Per share dataMRD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

MRD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

MRD has a Yearly Dividend Yield of 3.55%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.32, MRD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, MRD pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

The dividend of MRD decreases each year by -2.57%.
MRD has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.57%
Div Incr Years0
Div Non Decr Years0
MRD.CA Yearly Dividends per shareMRD.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

137.86% of the earnings are spent on dividend by MRD. This is not a sustainable payout ratio.
MRD's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP137.86%
EPS Next 2YN/A
EPS Next 3YN/A
MRD.CA Yearly Income VS Free CF VS DividendMRD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
MRD.CA Dividend Payout.MRD.CA Dividend Payout, showing the Payout Ratio.MRD.CA Dividend Payout.PayoutRetained Earnings

MELCOR DEVELOPMENTS LTD

TSX:MRD (11/3/2025, 7:00:00 PM)

14.5

-0.25 (-1.69%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-06 2025-11-06
Inst Owners8.76%
Inst Owner ChangeN/A
Ins Owners14.08%
Ins Owner ChangeN/A
Market Cap437.03M
Revenue(TTM)380.93M
Net Income(TTM)9.67M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Yearly Dividend0.44
Dividend Growth(5Y)-2.57%
DP137.86%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-15 2025-09-15 (0.13)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 51.79
Fwd PE 7.21
P/S 1.15
P/FCF 3.29
P/OCF 2.92
P/B 0.35
P/tB 0.35
EV/EBITDA 6.6
EPS(TTM)0.28
EY1.93%
EPS(NY)2.01
Fwd EY13.86%
FCF(TTM)4.41
FCFY30.42%
OCF(TTM)4.97
OCFY34.26%
SpS12.64
BVpS40.98
TBVpS40.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number16.07
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 0.78%
ROCE 7.22%
ROIC 5.2%
ROICexc 5.43%
ROICexgc 5.6%
OM 37.62%
PM (TTM) 2.54%
GM 47.53%
FCFM 34.89%
ROA(3y)2.91%
ROA(5y)2.39%
ROE(3y)5.16%
ROE(5y)4.32%
ROIC(3y)3.82%
ROIC(5y)3.63%
ROICexc(3y)3.93%
ROICexc(5y)3.72%
ROICexgc(3y)4.06%
ROICexgc(5y)3.84%
ROCE(3y)5.31%
ROCE(5y)5.03%
ROICexgc growth 3Y4.23%
ROICexgc growth 5Y17.72%
ROICexc growth 3Y4.16%
ROICexc growth 5Y17.7%
OM growth 3Y0.63%
OM growth 5Y5.89%
PM growth 3Y-18.68%
PM growth 5Y-11.95%
GM growth 3Y0.48%
GM growth 5Y-0.66%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.52
Debt/EBITDA 4.16
Cap/Depr 1376.95%
Cap/Sales 4.41%
Interest Coverage 250
Cash Conversion 103.58%
Profit Quality 1374.02%
Current Ratio 4.32
Quick Ratio 4.32
Altman-Z 1.62
F-Score7
WACC6.99%
ROIC/WACC0.74
Cap/Depr(3y)1460.36%
Cap/Depr(5y)1587.21%
Cap/Sales(3y)6.3%
Cap/Sales(5y)7.47%
Profit Quality(3y)95.67%
Profit Quality(5y)124.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-88.78%
EPS 3Y-13.69%
EPS 5Y-0.67%
EPS Q2Q%-68.66%
EPS Next Y-5.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.26%
Revenue growth 3Y3.46%
Revenue growth 5Y10.94%
Sales Q2Q%43.66%
Revenue Next Year-3.26%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.47%
EBIT growth 3Y4.12%
EBIT growth 5Y17.48%
EBIT Next Year-3.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6859.32%
FCF growth 3Y18.66%
FCF growth 5Y52.08%
OCF growth 1Y490.1%
OCF growth 3Y10.64%
OCF growth 5Y25.86%

MELCOR DEVELOPMENTS LTD / MRD.CA FAQ

What is the ChartMill fundamental rating of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MRD.CA.


What is the valuation status of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to MELCOR DEVELOPMENTS LTD (MRD.CA). This can be considered as Fairly Valued.


What is the profitability of MRD stock?

MELCOR DEVELOPMENTS LTD (MRD.CA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Price/Earnings (PE) ratio for MELCOR DEVELOPMENTS LTD (MRD.CA) is 51.79 and the Price/Book (PB) ratio is 0.35.


What is the expected EPS growth for MELCOR DEVELOPMENTS LTD (MRD.CA) stock?

The Earnings per Share (EPS) of MELCOR DEVELOPMENTS LTD (MRD.CA) is expected to decline by -5.24% in the next year.